
More than ever, drug makers need to be fleet and flexible-and they need their software to be the same.
Pieter Deurinck is a managing consultant and worldwide solutions architect for the Life Sciences/Pharmaceuticals team at IBM.

More than ever, drug makers need to be fleet and flexible-and they need their software to be the same.

Published: November 1st 2007 | Updated: